home / stock / ancn / ancn news

ANCN News and Press, Chemomab Therapeutics From 06/18/19

Stock Information
Company Name: Chemomab Therapeutics
Stock Symbol: ANCN
Market: NYSE
Website: chemomab.com
Menu
ANCN ANCN Quote ANCN Short ANCN News ANCN Articles ANCN Message Board
Get ANCN Alerts

News, Short Squeeze, Breakout and More Instantly...
ANCN - Anchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock Exchange

CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced that it completed the process to v...
ANCN - Anchiano Therapeutics Announces Appointment of Salar Roshan as Head of Business Development

CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced the appointment of Salar R...

ANCN - Anchiano Therapeutics reports Q1 results

Anchiano Therapeutics (NASDAQ: ANCN ): Q1 net loss of $18.45M More news on: Anchiano Therapeutics Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

ANCN - Anchiano Therapeutics Reports First Quarter 2019 Financial Results

– Closed $30.5 million U.S. Initial Public Offering in February 2019 – CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and d...
Previous 10 Next 10